With Bayer "badly broken in four places," now is not the right time to consider offloading its Consumer Health business, according to group CEO Bill Anderson. Bayer must focus its full attention for the next few years on addressing challenges which include mounting debt and costly litigation before a change to the company's structure can be considered.
Breaking up is hard to do, for Bayer at least. As it watches its biggest OTC rivals go solo, Bayer has decided to hold onto its Consumer Health business.
A six-month long strategic review led CEO Bill Anderson to conclude that offloading Consumer Health right now won’t solve the...
Create an account to read this article
Already a subscriber?
The global ingredients supplier has recently launched microbiome-focused products to expand its supplements offering and has more innovations in the pipeline.
Swedish probiotics player BioGaia is reaping the benefits of increased marketing investments and distribution in the US.
HBW Insight speaks to Prime Fifty founder and managing director Max Gowland about the science behind healthy aging and the opportunity for the consumer health industry.
Nature’s Bounty, Osteo Bi-Flex and Puritan’s Pride are among the dietary supplement brands under strategic review by Nestle as the firm shifts its focus to the premium end of the market.
Nutritional ingredient developer publishes results survey, with responses from 546 men and women in five countries, in a report looking at trends in cognitive and mood and with findings on consumers’ active nutrition goals, with a focus on the “concept of feeling good.”
Galenica's Swiss consumer health business Verfora is reaping the rewards of its expansion in the complementary medicine market with a solid showing in the first half of the year.
More than 7,000 distributors started a beta iteration of Pro2col in July Platform’s availability to additional US distributors =is planned for October, when it will launch with a Herbalife brand name.
